Eqt Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Europe may still await its first disease-modifying Alzheimer’s drug after the EMA postponed its decision on Leqembi (lecanemab, Biogen Inc./Eisai Co. Ltd) on March 22, but leading members of the World Dementia Council were in an optimistic mood when they convened in London four days later.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

The fund is focused on companies that are working to develop drug therapies and medical technologies for neurodegenerative diseases.